SOVEREIGN PHARMACEUTICAL, INC. - Research and Development

Research and Development
View Biographies of Senior Scientists

As part of Sovereign Pharmaceuticals commitment towards improvement in the product manufacturing and development of formulations, in October 2003, Research and Development (R & D) moved to a 7,200 square feet state of the art facility dedicated to the latest developments in the areas of industrial pharmacy.

Our capabilities include process development that emphasizes the experimental design approach for pre-screening of research formulations prior to scale-up. We have experience manufacturing the following dosage forms.

   • Suspensions.
   • Creams.
   • Ointments.
   • Liquids.
   • Oral solid dosage.

In addition, Sovereign has experience in the preparation of formulation systems designed to match the desired bioavailability of immediate and sustained release products, as well as expertise in developing fast dissolving tablets.

The Analytical Division of R&D is competent in the development and validation of analytical methods that meet the stringent requirements of new drug applications (NDAs) and abbreviated new drug applications (ANDAs). After method development, it is passed to the Quality Measurement Department for use in production testing. The efficiencies gained by this system allow Sovereign to get your product to market in the shortest time possible. Most analyses are performed using High Performance Liquid Chromatography (HPLC) instruments equipped with various detectors including Photodiode Array and Dual Absorbance.

Patents have been applied for some of our formulations methods and techniques.